Japan In-Vitro Diagnostics Market by Type (Reagents, Instruments, and Software & Services), by Technique (Immunodiagnostics, Hematology, Molecular Diagnostics, Tissue Diagnostics, Clinical Chemistry, and Other IVD Techniques), by Application (Infectious Diseases, Cancer, Cardiac Diseases, Immune System Disorders, Nephrological Diseases, Gastrointestinal Diseases, and Others), and by End User (Stand Alone, Laboratory, Hospitals, Academics and Medical Schools, Point of Care Testing, and Other End Users) – Opportunity Analysis and Industry Forecast, 2024–2030
Industry: Healthcare | Publish Date: 06-Jul-2024 | No of Pages: 139 | No. of Tables: 104 | No. of Figures: 69 | Format: PDF | Report Code : N/A
Speak to Our Analyst
Japan In-Vitro Diagnostics Market Overview
The Japan In-Vitro Diagnostics Market size was valued at USD 3.53 billion in 2023, and is predicted to reach USD 5.26 billion by 2030, at a CAGR of 5.4% from 2024 to 2030. In-vitro diagnostics (IVD) refers to a wide range of medical tests conducted on samples of bodily fluids, tissues, or cells outside of the body to diagnose diseases, monitor therapy, and assess overall health conditions. IVD tests are performed in laboratory settings using various techniques and technologies, including immunoassays, molecular diagnostics, clinical chemistry, hematology, and microbiology.
These tests enable early detection of diseases, allowing for timely intervention and treatment initiation. By providing rapid and accurate results, IVD tests facilitate personalized medicine, guiding tailored treatment approaches based on individual patient characteristics. Also, in-vitro experiments provide valuable insights into biological systems, enabling scientists and researchers to make significant contributions to fields such as medicine, biotechnology, and pharmacology. They serve as essential tools for understanding fundamental biological processes and developing innovative solutions to address health challenges.
Rising Aging Population in Japan Drives In-Vitro Diagnostics Market Growth
The rise in aging population boosts the demand for advanced diagnostics techniques such as in-vitro diagnostics. According to World Economic Forum, over 10% of Japan's population is now aged 80 or above. Additionally, approximately one-third of the population, totalling an estimated 36.23 million individuals, is aged over 65. The aging population in Japan not only signifies a demographic shift but also presents complex healthcare challenges that require innovative diagnostic solutions.
As individuals age, they become more susceptible to a range of health conditions, including chronic diseases such as cardiovascular diseases, diabetes, and neurological disorders. The need for early detection, accurate diagnosis, and personalized treatment options becomes paramount in ensuring the well-being of the elderly population and as a result, manufacturers are focusing on developing in-vitro diagnostics tests products that cater specifically to the needs of the aging population, offering improved accuracy, sensitivity, and usability.
New Product Launches by Key Players Drive Innovation and Growth in the Market
The continuous introduction of new products by key players such as Sysmex Corporation enhances competition and innovation within the in-vitro diagnostics market and further driving the market growth in Japan. For instance, in May 2023, Sysmex Corporation has recently unveiled its latest clinical flow cytometry system in Japan, marking a significant milestone in the domain of immunodiagnostics.
This state-of-the-art system is designed to elevate diagnostic capabilities in haematology and oncology by offering precise and efficient analysis of blood and tissue samples. With its advanced technology and features tailored for clinical flow cytometry, the new system holds great promise for enhancing the accuracy and reliability of diagnostic procedures, particularly in the detection and monitoring of haematological and oncological disorders.
High Research, Development, and Regulatory Approval Costs Hinder the Market Growth
High costs associated with research, development, and regulatory approval are significant factors restraining the Japan IVD market growth. Operating within this sector necessitates significant financial investment for companies to navigate the complex landscape of research and development.
This investment often encompasses extensive clinical trials, laboratory testing, and product refinement to guarantee accuracy and reliability. Additionally, obtaining regulatory approvals from agencies such as the FDA requires strict adherence to stringent standards, further compounding the financial burden. This financial constraint can discourage potential adopters from market expansion.
Introduction of Point-of-Care Testing Solutions in IVD Creates Market Opportunity
Point-of-care testing (POCT) is poised to significantly drive the Japan in-vitro diagnostics market demand in the forthcoming years. POCT serves as a valuable complement to laboratory testing, especially in situations where immediate results are crucial, such as emergency departments, ambulances, and remote healthcare settings.
With POCT technologies offering rapid tests for infectious diseases, cardiac biomarkers, glucose monitoring, pregnancy testing, and more, healthcare providers can quickly assess patients' conditions and make timely treatment decisions. By integrating POCT with traditional IVD, healthcare providers can enhance their medical diagnostic capabilities, delivering more efficient and patient-centered care. This integration streamlines workflows, allowing for faster diagnosis and treatment initiation, ultimately leading to improved patient outcomes.
Competitive Landscape
The promising players operating in the Japan in-vitro diagnostics industry include Roche Holding AG, Abbott Laboratories, Thermo Fisher Scientific Inc, Danaher Corporation, Becton, Dickinson and Company, Siemens Healthineers AG, bioMérieux SA, Sysmex Corporation, QIAGEN N.V., and Bio-Rad Laboratories, Inc., and others.
Japan In-Vitro Diagnostics Market Key Segments
By Type
-
Reagents
-
Instruments
-
Software & Services
By Technique
-
Immunodiagnostics
-
Enzyme-Linked Immunosorbent Assay (ELISA)
-
Rapid Tests
-
Chemiluminescence Immunoassay (CLIA)
-
Enzyme-linked Immunosorbent spot (ELISpot)
-
Radioimmunoassay (RIA)
-
Western Blot
-
-
Hematology
-
Molecular Diagnostics
-
PCR
-
INAAT
-
Hybridization
-
DNA diagnostics
-
Microarray
-
Other Molecular Diagnostics
-
-
Tissue Diagnostics
-
Clinical Chemistry
-
Basic Metabolic Panel
-
Liver Panel
-
Renal Profile
-
Lipid Profile
-
Thyroid Function Panel
-
Electrolyte Panel
-
Speciality Chemicals
-
-
Other IVD Techniques
By Application
-
Infectious Diseases
-
Cancer
-
Cardiac Diseases
-
Immune System Disorders
-
Nephrological Diseases
-
Gastrointestinal Diseases
-
Others
By End User
-
Stand Alone Laboratory
-
Hospitals
-
Academics and Medical Schools
-
Point of Care Testing
-
Other End Users
REPORT SCOPE AND SEGMENTATION:
|
Parameters |
Details |
|
Market Size Value in 2023 |
USD 3.53 billion |
|
Revenue Forecast in 2030 |
USD 5.26 billion |
|
Value Growth Rate |
CAGR of 2.7% from 2024 to 2030 |
|
Analysis Period |
2023–2030 |
|
Base Year Considered |
2023 |
|
Forecast Period |
2024–2030 |
|
Market Size Estimation |
Billion (USD) |
|
Growth Factors |
|
|
Companies Profiled |
10 |
|
Customization Scope |
Free customization (equivalent up to 80 working hours of analysts) after purchase. Addition or alteration to country, regional, and segment scope. |
|
Pricing and Purchase Options |
Avail customized purchase options to meet your exact research needs. |
KEY PLAYERS
-
Roche Holding AG
-
Abbott Laboratories
-
Thermo Fisher Scientific Inc.
-
Danaher Corporation
-
Becton, Dickinson and Company
-
Siemens Healthineers AG
-
bioMérieux SA
-
Sysmex Corporation
-
QIAGEN N.V.
-
Bio-Rad Laboratories, Inc.
Frequently Asked Questions
Download Free Sample
Related Report
Related Blogs
Technological Advancements Shaping The Minimally Invasive Surgical Systems Market
Introduction The landscape of medical interventions is unde...
Revolutionizing Kidney Health: Latest Trends and Advancements in Dialysis Technology
Introduction Dialysis, a crucial medical procedure, is carr...
Transforming Healthcare With Patient Monitoring Innovations
Introduction Patient monitoring refers to the continuous or periodic observatio...
